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Tinnitus is defined as the perception of sound in the absence of an external source. It is often associated with hearing loss and is
thought to result from abnormal neural activity at some point or points in the auditory pathway, which is incorrectly interpreted by
the brain as an actual sound. Neurostimulation therapies therefore, which interfere on some level with that abnormal activity, are
a logical approach to treatment. For tinnitus, where the pathological neuronal activity might be associated with auditory and other
areas of the brain, interventions using electromagnetic, electrical, or acoustic stimuli separately, or paired electrical and acoustic
stimuli, have been proposed as treatments. Neurostimulation therapies should modulate neural activity to deliver a permanent
reduction in tinnitus percept by driving the neuroplastic changes necessary to interrupt abnormal levels of oscillatory cortical
activity and restore typical levels of activity. This change in activity should alter or interrupt the tinnitus percept (reduction or
extinction) making it less bothersome. Here we review developments in therapies involving electrical stimulation of the ear, head,
cranial nerve, or cortex in the treatment of tinnitus which demonstrably, or are hypothesised to, interrupt pathological neuronal
activity in the cortex associated with tinnitus.
1. Introduction
Tinnitus affects about 16% of the adult population [1, 2]
and is strongly associated with hearing loss [3]. There is as
yet no cure and so clinical management typically involved
education and sound-based therapies [4]. It is associated with
pathological neural activity in the central auditory system,
possibly resulting from suboptimal or maladaptive response
to a peripheral lesion (hearing loss) within a certain fre-
quency range resulting from ageing [5] or noise exposure [6].
While the loss of cochlear hair cells causes elevated thresholds
in that frequency range, at the same time spontaneous activity
of several auditory structures can be enhanced. Increased
spontaneous firing rate and spike-timing dependent plasticity
facilitate increased synchrony of firingwithin and across neu-
ral assemblies; both hyperactivity and increased synchrony
are proposed as neural correlates of tinnitus [7, 8]. Although
it is difficult to separate contributions of the twomechanisms
based solely on experimental data [9], a recent review of
physiological evidence suggests that changes in spontaneous
firing alone are unlikely to generate a tinnitus percept [10].
In the intact brain, transient synchronization of neuronal
oscillatory activity is thought to be the mechanism that
facilitates functional connectivity between different regions,
which binds the activity from distributed neural ensembles
into a coherent representation of cognitive and sensory
functions [11]. Conversely, altered synchronization has been
observed in a number of psychiatric and cognitive conditions,
including schizophrenia [12], Alzheimer’s disease [13], and
attentional deficits [14]. Likewise, in tinnitus, a number of
studies have reported tinnitus-related functional connectivity
between disparate regions of the brain based on brain
oscillations; for example, connectivity between the anterior
cingulate cortex (ACC) and both the right frontal lobe and
right parietal lobe strongly correlates with tinnitus distress
[15–17]. Studies typically attempt to correlate brain oscil-
lations and their interregional statistical interdependencies
with observed changes in perception and behaviour. More
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recently, a number of studies take an alternative approach
in that they attempt to alter brain oscillations by means of
brain stimulation to observe changes in behaviour. This is
based on the assumption that modulating brain rhythmsmay
affect cognitive performance and thus can be used to treat
neurological disorders. Numerous studies overmany decades
indicate that low-intensity electrical currents can modulate
network dynamics noninvasively in humans. Electrical stim-
ulation has also been applied invasively in humans, either
on the cortical surface or as deep implanted electrodes [18].
However, the precise neural mechanism by which changes
occur at both local and network levels is not fully understood
(for a review of the animal literature see Reato et al. [19]).
It is not clear how the effects at the single neuronal level
influence the network activity both spatially and temporally.
Moreover, with regard to noninvasive techniques, it is not
knownwhich precise location of the brain is being stimulated.
Nevertheless, studies report changes in perception during or
following electrical stimulation of the brain.
To date, a small number of neurostimulation techniques
for tinnitus have been the subject of either a systematic review
and meta-analysis (transcranial Direct Current Stimulation
(tDCS) [20], cochlear implantation [21, 22]) or a scoping
review (tDCS [23]). Here the objective was to scope the
literature on approaches to electrical stimulation of the ear,
head, cranial nerve, or cortex for tinnitus which are more
experimental insofar as they have not yet been the subject of
a scoping or systematic review.
2. Methods
All study types were included in this scoping review. Inclu-
sion was determined according to the implementation of
an intervention of interest and the measurement of an
outcome of interest. Interventions included in this review
used noninvasive electrical stimulation of the ear, tran-
scranial alternating current stimulation (tACS), vagal nerve
stimulation (VNS), transcutaneous vagal nerve stimulation
(tVNS), procedures involving direct cortical stimulation,
or paired electrical and acoustic stimulation. In terms of
outcomes, of interest was whether the intervention had any
potential clinical effect on symptom severity, measured as the
global score on a self-report measure of tinnitus, generalised
anxiety, depression, or quality of life, and equally whether
there were adverse effects of the intervention. Our second
interest was the potential neurophysiological mechanisms
of any effects, for example, change in neurophysiological
function asmeasured bymagnetoencephalography (MEG) or
electroencephalography (EEG).
2.1. Search Strategy. Studies were identified from the results
of electronic database searches. Databases were PubMed,
Web of Science, and Google Scholar. Database searches were
conducted inDecember 2015 using the search termsTinnitus,
OR tinnit∗, AND (Transcutaneous Electric Nerve Stimula-
tion) OR (Vagus Nerve Stimulation) OR (Electric Stimula-
tion) OR (Electric Stimulation Therapy) OR (tACS or VNS
or tVNS) OR (neuromodulat∗ or neurostim∗) OR (vagus
or vagal or transcutaneous or transcranial or Transdermal
or Percutaneous or cutaneous or AC near stimul∗) OR
(alternating near current near stimul∗) OR (Electrostimul∗
or neurostimulation or electro-stimul∗ or neuro-stimul∗ or
“electro stimul∗” or neuro stimul∗) OR (electrical stimul∗ or
electric stimul∗).
To identify ongoing or unpublished trials we searched
ClinicalTrials.gov and conducted a hand search for recently
published study protocols relevant to this review.
3. Results and Discussion
From initial 642 search records, 46 studies were selected
for full-text review by DH. All authors then independently
selected relevant studies according to our inclusion criteria.
Nineteen human studiesmet our criteria for inclusion and are
reviewed here by class of intervention. These included three
studies using noninvasive electrical stimulation of the ear
(reported 2013-2014), two studies of transcranial alternating
current stimulation (tACS) (reported 2013-2014), one pilot
study and one case study using vagal nerve stimulation (VNS)
(reported 2014-2015), five studies using transcutaneous vagal
nerve stimulation (tVNS) (reported 2012–2015), one study
examining vestibulocochlear nerve stimulation (reported in
2007), and seven studies involving different forms of direct
cortical stimulation (reported 2004–2015). A summary of
findings from clinical studies is given in Table 1.
3.1. Noninvasive Electrical Stimulation of the Ear. Suppression
of tinnitus by electrical stimulation of the preauricular skin,
mastoid, eardrum, promontory, and round window and
within the cochlea has been employed formany years [24, 25].
Efficacy of the electrical stimulation reported by some early
studies varies from 7 to 82% of patients perceiving benefit
for their tinnitus [24–35]. A more recent study by Mielczarek
et al. [36] assessed the effectiveness of electrical stimulation
of the hearing organ on tinnitus (severity not measured)
in patients with cervical spine degeneration, also examining
any additive effect of cervical spine kinesitherapy (therapy
involving muscle movement) on tinnitus. The frequency of
the stimulation, delivered through the electrode placed in
the ear canal targeting the cochlea, was adapted according
to tinnitus frequency. The treatment involved 15 applications
of 4min electrical stimulation 3-4 times a week. After the
treatment in both groups the number of ears (location not
specified)with permanent tinnitus decreased from88% in the
group with electrical stimulation only and 90% in the group
with combined electrical stimulation and kinesitherapy to 43
and 54%, respectively. In 37% of ears after electrical stim-
ulation and 28% of ears after combined treatment tinnitus
disappeared completely. In addition self-reported and audio-
metric improvement of hearing was noted in both groups, in
34% and 26% of ears, respectively. This study was followed
by a double-blind placebo-controlled study in 120 patients
using the same method of electrical stimulation of the ear
[37]. The placebo involved application of the electrode to the
ear canal without any current. Similar to their earlier study,
proportion of ears with permanent tinnitus decreased from
89% before treatment to 49% immediately after treatment. In
34% of ears tinnitus disappeared completely. Interestingly, in
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the placebo group, the proportion of ears with tinnitus also
decreased immediately after the control from 86% to 71%.
Tinnitus disappeared completely in four ears in the control
group. However, the effect was reported as stable in the
treatment group after 30 and 90 days; the placebo effect was
not maintained. Moreover, in the treatment group, there was
a statistically significant improvement in audiometric thresh-
olds, with patients also reporting subjective improvement in
30% of ears. There was no deterioration of hearing after the
treatment. Whilst impressive, tinnitus was not measured in
these studies using a multi-item tinnitus questionnaire so the
results have to be considered with caution.
Lee et al. [38] investigated effectiveness of transcutaneous
electrical nerve stimulation (TENS) applied to the external
pinna in 65 participants with moderate severity tinnitus
(randomized such that 45 were in the treatment arm and
20 received sham stimulation). Participants received TENS
treatment twice a week for four weeks. Only two participants
had a long-term improvement after treatment with TENS
(effects maintained at three months) and it was noted that
both had low frequency tinnitus and milder hearing losses.
It would be interesting to evaluate TENS in a group with
these characteristics. No studies of TENS for tinnitus were
identified as ongoing, and a systematic review is not indicated
at present.
3.2. Transcranial Alternating Current Stimulation (tACS).
tACS involves the delivery of alternating current (constant
polarity changes) between electrodes placed on the skin over
cortical regions of interest. It is hypothesised to affect upregu-
lation and downregulation of synapses andmay have an effect
on oscillatory cortical activity, indicating it for tinnitus [39].
In the first study of its kind Vanneste et al. [40] compared
single session tACS, tDCS, and transcranial random noise
stimulation (tRNS; equating to tACSmodified to have a 0mA
offset applied at random frequencies; frequencies ranged
from 0.1 to 100Hz). One hundred and eleven tinnitus patients
were randomly assigned to the three study arms. The main
outcomes were tinnitus loudness and annoyance, measured
before and after treatment on a 10-point numeric rating
scale. Only the group receiving tRNS showed significant
within and between group effects of the intervention, on both
rating scales, with the authors concluding this to be the most
clinically effective for transient tinnitus suppression within a
single session. It was suggested that the lack of an effect of
tACS might have been due to the rather weak current used
(1.5mA for 20min), a consideration for future studies.
Vanneste et al. [41] also compared tinnitus suppression
using single sessions of individual alpha-modulated tACS
or tDCS in a randomized placebo-controlled study. Fifty
participants were randomly allocated to receive either real
stimulation (up to 10mA and lasting 20 minutes) or sham
stimulation (current was turned off after 30 seconds). Again,
the main outcomes were tinnitus loudness and annoyance,
measured on a 10-point numeric rating scale. EEG was also
recorded immediately after treatment for those receiving real
tACS. The authors reported a positive effect of tDCS ratings
of tinnitus loudness or annoyance but no significant effect
of tACS compared to sham stimulation. EEG analyses also
showed no effect on power between pre- and post-tACS.
Most recently, in a retrospective analysis of 228 patients
who received therapy for tinnitus, Claes et al. [42] exam-
ined the effects of single or repeated sessions of alpha-
modulated tACS (ramped to 2.0mA) and tRNS as described
earlier. Effects on tinnitus loudness and annoyance were
measured using simple 10-point numeric rating scales. In
both interventions stimulation was applied to the auditory
cortex in sessions lasting 20 minutes. In this study, tACS
had no effect on tinnitus. tRNS however was associated with
reduced tinnitus loudness, both within a single session and
additively across sessions. tRNS was also associated with an
improvement after a single session; multiple sessions had no
additive effect. Physiological effects were not measured.
The study of tACS is therefore at an early stage, although
there are no strong indicators for further study, and no studies
were identified as ongoing. However, the studies reported
here were all conducted by the same research group. Current
protocols need replication to discount them, and alternative
protocols should explore the optimal conditions of tACS and
whether any subgroups of tinnitus patient show benefit. As
discussed by Claes et al. [42], potential influencing variables
including age, sex, and tinnitus characteristics need to be
considered as variables in future work.
tRNS is the subject of at least two ongoing studies.
Langguth and colleagues are conducting a safety/feasibil-
ity/efficacy study (NCT01965028) with 30 participants, all
receiving high-frequency tRNS daily for two weeks, with a
primary outcome of number of participants with a ≥5-point
tinnitus questionnaire (TQ [43]) score at long-term follow-
up. This contrasts with previous studies where only acute
effects were measured and simple rating scales as opposed
to clinical questionnaire tools were used. The same group
are also examining the safety/feasibility/efficacy of daily low
frequency tRNS (NCT02615600) using the same protocol.
3.3. Vagal Nerve Stimulation (VNS): General Concept and
Animal Studies. One of the postulated ways of reversing the
pathological plastic changes in the auditory system associated
with hearing loss and tinnitus is through targeted auditory
stimulation or auditory discrimination training [44]. How-
ever, to date, the clinical benefit of auditory stimulation
approaches to treating tinnitus has been limited [45] and
only temporary relief has been demonstrated. It is postulated
that auditory stimulation alone is not enough to affect plastic
changes in the brain and so research attention has shifted to
the forebrain cholinergic and noradrenergic systems that play
a significant role in modulating cortical plasticity. Studies in
animals looking at the electrical stimulation of the cholinergic
nucleus basalis provided evidence for pronounced and long-
lasting changes in cortical reorganization [46] and led to the
idea that pairing auditory stimulation with electrical stimula-
tion could be used to treat tinnitus [47]. However, stimulation
of the nucleus basalis is an invasive procedure and therefore
not a viable option for widespread use in tinnitus patients.
In 2011, Engineer and colleagues published a study look-
ing to obtain similar effect to nucleus basalis stimulation but
using much less invasive electrical stimulation of the vagus
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nerve (10th cranial nerve; VNS) in noise-exposed rats [48].
The VNS approach was considered promising as previous
clinical studies showed it can alleviate epilepsy [49] and
depression [50]; it is now a Food and Drug Administration
approved treatment for drug-resistant epilepsy and depres-
sion. Engineer et al. [48] used adult rats with noise-induced
hearing loss presumed to have a related tinnitus in the
region of 8–10 kHz as verified with the startle reflex paradigm
[51]. Noise-exposed rats showed a significant cortical map
distortion, decreased frequency selectivity, increased tone-
evoked response, and increased spontaneous neural activity
in the auditory cortex and increased cortical neural syn-
chrony. A regime consisting of acoustic stimulation com-
posed of multiple tones at frequencies outside the tinnitus
region, paired with VNS, was associated with reversal of
both behavioural and physiological markers of tinnitus,
except for increased spontaneous activity which was still
observed. Neither acoustic stimulation alone nor VNS alone
led to the same changes. The authors postulated that while
acoustic stimuli are essential to activating particular neural
populations within the auditory cortex (to be able to target
neuroplastic change), the VNS component of the treatment
was essential to promoting those plastic changes through
what Engineer et al. [48] term as “synergistic action of
multiple neuromodulators.” Specifically, it was postulated
that acetylcholine and muscarinic receptors are involved in
VNS mechanism of action [48, 52].
3.4. Human Studies Using Implanted VNS. Several studies
explored the safety and efficacy of the VNS paired with
acoustic stimulation in humans. De Ridder and colleagues
[53] conducted a pilot study with 10 participants with
chronic moderate-to-catastrophic tinnitus severity tinnitus.
Participants received 2.5-hour treatment for 20 days. The
patients heard tones, excluding the tinnitus-matched fre-
quency, paired with brief electrical stimulation of the vagus
nerve. Both clinical and physiological (electroencephalog-
raphy, EEG) effects of VNS were reported. Whole group
analysis revealed a decrease in Tinnitus Handicap Inventory
(THI [54]) score of 11% immediately after the treatment
and 12% at four-week follow-up relative to baseline (not
a clinically significant score change). Exploratory analyses
suggested that taking psychoactive medications such as
antidepressants may inhibit the benefit to be had from the
treatment. The mean decrease in THI scores for nondrug
group was 29% immediately after treatment and 26% at
follow-up, while for the drug group the change was minimal.
Authors also reported a more pronounced reduction of
Minimum Masking Levels (MMLs) in the nondrug group
(18.8 dB reduction) than in the drug group (4.3 dB reduction).
From EGG recordings (performed in 7 participants only due
to technical problems) they concluded that VNS decreased
band power in the delta (1–4Hz) and theta (4–8Hz) bands
in subjects who responded to therapy, with increased band
power in those bands observed in subjects who did not
respond to the therapy. For both delta and theta bands the
difference in band power change between VNS and sham
trials strongly correlated with their THI scores (𝑟 ≥ 0.74).
There are several caveats about the results of that study
however. Only one participant had a clinically significant
improvement (20 or more points) on the THI, 6 had an
improvement that was not clinically meaningful, and 3 had
a slightly worse THI score after treatments. As the study
was uncontrolled placebo effects are not accounted for. It
is worth noting too that all participants in the study had
undergone between 3 and 8 previous treatments for tinnitus
with medication, neurofeedback therapy, hearing devices,
tinnitus masker devices, various other noninvasive forms of
electrical stimulation, or cortical implantation.
A recent case report from the same research group
compared the effects ofVNS to the effects of sham stimulation
in a 59-year-old man with refractory tinnitus [55]. It is not
clear if the patient was one of the participants in the previous
study. The methods used were the same as before with the
exception that for 2 months (washout period) after paired
VNS treatment the patient received sham stimulation (only
tone presentation without the simultaneous electrical stim-
uli). After four weeks of VNS treatment the patient showed
a reduction in THI scores of 48% and Tinnitus Reaction
Questionnaire (TRQ [56]) scores by 68%. In contrast, sham
stimulation led to a 27% increase in THI and 15% increase in
TRQ scores. Again, VNS was observed to induce changes in
the resting state oscillatory brain activity as measured with
EEG. A significant decrease in relative power in the delta,
theta, alpha, beta, and gamma frequency band was observed
after VNS, suggestive of desynchronization; no changes were
observed as a result of the sham stimulation.
It is worth noting that implantation of the vagal nerve
stimulator is a full surgical procedure performed under
general anaesthetic. This procedure is invasive and carries
both short- and long-term risks. While authors stated that no
major adverse events were observed in either study, several
adverse effects of either the surgery or stimulationwere listed,
including infection of the extension lead requiring removal
of the lead and electrode, inflammation at the abdominal
surgical site, hoarseness during stimulation, transient left
vocal cord hypomobility, and temporary increases in tinnitus
symptoms. MicroTransponder Inc. have recently completed
recruitment to a pilot study (NCT01962558) involving 30
participants randomized to receive either (1) VNS pairedwith
tones or (2) VNS and unpaired tones hypothesised to be
ineffective for tinnitus. The results of this study will be very
informative for further clinical investigation.
3.5. Human Studies Using Transcutaneous VNS. An alterna-
tive noninvasive approach using transcutaneous stimulation
of the vagus nerve (tVNS) is considered in parallel. Several
studies examining the safety and efficacy of tVNS either alone
or paired with acoustic stimulation have been conducted
in recent years. Two consecutive reports from Kreutzer and
colleagues [57, 58] describe the results of the single-arm
pilot study looking at the tVNS without acoustic stimulation.
The study was conducted in two phases, with different
groups of participants with tinnitus in each phase. The first
phase of the study was terminated early due to two cardiac
events and was followed by detailed analysis of the ECG
data collected throughout the study in all participants [57].
Authors concluded it was very unlikely that the events were
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caused by the tVNS device and the study progressed to phase
2. Analysis of the results from both phases showed that tVNS
was suitable for long-term use, but without the use of paired
acoustic stimuli it appeared to have no effect on tinnitus.
Reductions in TQ scores were minimal (4 ± 8 in phase I
and 3 ± 9 in phase II) and dropout was high (10 out of
23 patients in phase I and 6 out of 21 in phase II). This
suggests that the treatment protocol, consisting of several
hours of stimulation over 6 months, if effective at all might
only be feasible for some patients. In addition, a number of
adverse events were associated with the treatment including
tingling sensation, dysesthesia, skin redness and pressure
marks at the stimulation sites, painful stimulation, dyspnea
of low intensity, headaches, hoarseness, nausea, and transient
subjective hearing impairment. Overall it was concluded that
tVNS was safe for prolonged use in patients without a history
of cardiac disease.
Two studies have examined tVNS paired with acoustic
stimulation in humans. Lehtima¨ki et al. [59] conducted
a single-armed pilot study using music as their acoustic
stimulus. The music was filtered of any frequencies that
sounded like the individuals tinnitus. The treatment resulted
in improvements in mood as measured with the WHO 5-
point well-being questionnaire [60]. The mean well-being
score increased from 56 points at baseline to 76 points
after treatment. THI (severe at baseline) and mini-TQ ques-
tionnaire score decreased significantly, and subjective loud-
ness and annoyance, measured with visual analogue scales
(VAS), were also reduced after treatment. The auditory N1m
response to the tinnitus frequency, measured by magnetoen-
cephalography (MEG), was compared as “tVNS on” versus
the “tVNS off” conditions; tVNS decreased the amplitude of
the auditory N1m response, while the peak latencies did not
change. Authors stressed the importance of these findings as a
first demonstration of acute neuromodulative effects of tVNS
on evoked auditory cortical responses. Safety of the tVNSwas
confirmed as no adverse events were reported.
Hyva¨rinen et al. [61] compared cortical oscillatory power
(power spectral density, PSD) and synchronization (phase lag
index, PLI) in people with moderately severe tinnitus and
normally hearing controls using MEG. Specifically, baseline
activity when the tVNS was not activated was compared
between groups aswell as differences in tone-evoked (tinnitus
frequency in participants with tinnitus and 1 kHz in controls)
brain activity between tVNSnot activated and tVNS activated
conditions in the tinnitus group. The results revealed higher
PSDs in gamma band at baseline in tinnitus than in control
group and higher PLIs particularly in beta and gamma bands
in tinnitus patients compared to controls. tVNS had different
effects on synchronicity in people with tinnitus and controls.
In the tinnitus group, whole-head alpha activity, occipital
alpha, and right temporal gamma activity increased during
stimulation, and occipital theta activity decreased in response
to tVNS.Hyva¨rinen et al. [61] also investigated the correlation
of each measure with individual THI scores. Higher whole-
head beta (𝑟 = 0.74), low temporal delta (𝑟 = −0.74), and
low temporal theta (𝑟 = −0.71) were associated with higher
THI scores when the tVNS was not activated. In addition,
THI scores also correlated positively with the tVNS induced
change in normalized PSD values for multiple frequency
bands and brain regions. tVNS induced changes in synchrony
correlated strongly with THI scores, at whole-head beta (𝑟 =
−0.86), whole-head gamma (𝑟 = −0.95), and frontal gamma
bands (𝑟 = −0.95). Overall, the picture is quite complicated
and needs further investigation.
One study of tVNS for tinnitus is identified as ongoing.
Li et al. [62] are conducting a randomized, single-blind,
controlled clinical study (ChiCTR-TRC-14004940) compar-
ing (1) tVNS only, (2) tVNS paired with sound stimuli, (3)
nonvagus electrical stimulation of the outer ear, and (4)
an electrical acupuncture group. They aim to recruit 120
participants and are using the THI as their primary outcome
measure. As this questionnaire was also used in both previous
studies of tVNS, the outcome of this study can be usefully
compared or synthesised with existing data.
3.6. Chronic Electrical Vestibulocochlear Nerve Stimulation
(VCNS). An interesting alternative to the VNS is chronic
electrical vestibulocochlear nerve stimulation (VCNS),where
the stimulation electrode is surgically placed around the
vestibulocochlear nerve and connected to a pulse generator
placed under the skin [63]. In this approach the auditory
pathways are stimulated directly. Bartels and colleagues [63]
investigated safety and efficacy of this method in six par-
ticipants with unilateral, severe, chronic refractory tinnitus
and severe hearing loss in the tinnitus ear. Two participants
dropped out, one due to the neurostimulation being unsuc-
cessful after a period of three months and one due to other
health and psychiatric problems not due to tinnitus, leaving
four participants for long-term evaluation (42.5 months on
average).
No side effects from VCNS were reported during long-
term evaluation. Mean THI scores reduced from 77 points at
the baseline to 55 points at 3 months and 38 points at long-
term follow-up. This equated to a large clinical effect size
(𝑑 = 1.75) at follow-up. For two participants, THI score was
reduced after 3months and for the other twoparticipants THI
scores were reduced after about 6 months of treatment. Self-
rating of tinnitus severity was also reduced on a 10-point scale
from a mean of 8 to 3 at long-term follow-up. As described
by authors, while none of the participants’ tinnitus disap-
peared during the treatment, “all patients reported that the
neurostimulation system transformed intrusive combination of
noises into a single, pleasantly-perceived noise” ([63] p.134).
No new studies of VCNS for tinnitus were identified as
ongoing.
3.7. Brain Surface Stimulation. The earliest report of invasive
electrical stimulation in tinnitus was provided by De Ridder
et al. [64] who demonstrated suppression of tinnitus in a
single patient following focal electrical stimulation of the
primary auditory cortex. The patient, a 32-year-old woman,
suffered from severe left-sided tinnitus following total loss
of hearing in the left ear. Tinnitus was rated 9 on a 10-
point VAS, and loudness was matched to an 80 dB external
tone and between 8 and 9 kHz. Initially, TMS was applied
to the right auditory cortex following functional magnetic
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resonance imaging (fMRI) to identify Heschl’s gyrus. Tin-
nitus was completely abolished beyond the duration of
stimulation. Subsequently, an extradural octopolar electrode
was implanted onto the right auditory cortex for electrical
stimulation via a neurostimulator which generated and deliv-
ered 0.5msec pulses at a rate of 40 pps and 2.7mA, to which
the patient’s tinnitus disappeared completely. However, three
weeks after the operation, high-pitched tinnitus returned.
The authors suggested this was due to cortical plasticity in
response to constant stimulation at the high-frequency areas
but could not explain how electrical stimulation of the cortex
eliminated tinnitus.
Following their initial study, De Ridder et al. [18] exam-
ined the effect of implanted electrodes in a group of patients
with moderate-to-severe tinnitus. Based on the similarity
of tinnitus with pain, and the assumption that the sound
is generated in the central nervous system, the authors
argued that at least some forms of tinnitus are caused
by neural plasticity and the reorganization of the central
nervous system involving the auditory cortex. In addition,
they assume that neural hyperactivity within the auditory
system underlies the tinnitus abnormality.They thus propose
that tinnitus can be treated by suppressing this hyperactivity
by means of implanted electrodes in both the primary and
secondary auditory cortices. They selected 12 participants
who reported their tinnitus to be suppressed by at least 50%
on a visual analogue scale by application of TMS. Primary
and secondary auditory cortices were first localised using
fMRI and frequency specific sounds (matched to tinnitus
pitch), supposed to improve accuracy of finding the tinnitus
“generator” in the auditory cortex. Two-pole electrodes were
positioned such that one was intradural, on the primary
auditory cortex, and the other was extradural, overlaying the
secondary auditory cortex. The results were as follows: stim-
ulation through the extradural electrode resulted in tinnitus
suppression of 26% for patients with white noise tinnitus and
97% for those with pure tone tinnitus. As for the intradural
electrodes, percentage suppression was not reported but only
2 patients failed to report an improvement in tinnitus, which
suggests stimulation of primary auditory cortex provides
more lasting suppression. Overall, patients with unilateral
tinnitus reported better suppression than those with bilateral
tinnitus. Moreover, in patients with white noise and pure
tone tinnitus, electrical stimulation suppressed the pure tone
tinnitus, while the white noise tinnitus remained unchanged.
Importantly, tinnitus reappeared at some later time beyond
the main study but it is not clear how long after the operation
their tinnitus returned to its preoperative levels. The authors
suggest that the intensity of the perceived tinnitus is related to
the degree of cortical reorganization; however, this has since
been shown not to be the case by a number of studies (e.g.,
see Sereda et al. [3]). Moreover, the assumption that tinnitus
is generated within the auditory cortex, which guided the
implantation loci, has not been established.
Seidman et al. [65] followed a similar procedure. Their
reasoning was based on the thalamocortical dysrhythmia
model [66, 67] which suggests that tinnitus emerges as a
result of peripheral damage and deafferentation, leading to
reduced neural firing rates in corresponding thalamocortical
columns. Consequently, this leads to hyperactivity in the
neighbouring regions (“edge effect”) and characteristic 40Hz
oscillations as the correlate of tinnitus. They therefore
attempted to generate a therapeutic benefit by introducing an
electrical signal in the vicinity of this reorganized auditory
cortex. In two patients with chronic severe tinnitus, they
first attempted to identify the tonotopic maps in Heschl’s
gyrus using MEG and fMRI, before implanting electrodes
within areas showing increased activity. Electrode arrays
were advanced into the brain tissue in Heschl’s gyrus and in
proximity to the area localised noninvasively. In one patient
with bilateral, high-pitched tinnitus, loudness decreased sig-
nificantly in both ears as the pulse generator was activated. In
follow-up evaluations, this patient reported that tinnitus has
remained significantly reduced (visual analogue scale rating).
In the second patient with unilateral left-sided high-pitch
narrow band tinnitus, neurostimulation was less successful.
Several attempts at stimulation treatments over a period of
two years did not diminish tinnitus. The reason for this
discrepancy is not clear. The authors suggest that while
electrical stimulation is clearly beneficial, perhaps in some
patients areas such as the amygdala or hippocampus should
be stimulated instead of the auditory cortex.
Most recently, De Ridder and Vanneste [68] report the
case of a single tinnitus patient who experienced beneficial
effect of an auditory cortex implant. In this study auditory
cortex stimulation and C2 nerve stimulation were combined
using implanted electrodes overlying the auditory cortex
and subcutaneous electrodes modulating the C2 dermatome.
It has been found that auditory deafferentation induces
compensatory increases of somatosensory influences on the
auditory pathways at the level of the dorsal cochlear nucleus
[69] and that C2 electrical stimulation can suppress or
enhance responses to sound via a pattern of inhibition
and excitation of the principal cells in the ventral and
dorsal division of the cochlear nucleus. It was hypothesised
therefore that cross-modal convergence or interaction of
multisensory neurons, whereby the modulation of activity
evoked by one modality modulates the activity evoked by
another [70], could be beneficial.The participant had suffered
from severe unilateral right-sided tinnitus for 1.5 years prior
to testing. Subjective tinnitus loudness score was 8.5/10 on
a 10-point scale, matched to a 6 kHz with an audiometric
threshold that also dipped at 6 kHz. The patient had no
sign of somatosensory modulation of tinnitus. fMRI was
performed to identify the auditory cortex and subsequently
an electrode was implanted overlying the secondary auditory
cortex. The authors report a complete suppression of the
pure tone component of the tinnitus; however, the noise-
like component was only suppressed to 4 on a 10-point scale,
which worsened again. Subsequently, transcutaneous electri-
cal nerve stimulation (TENS) at C2 reduced the noise from
7 to 1-2/10 consistently over 4 weekly sessions. The patient
used the TENS on a daily basis with good result but after
3 months the effect diminished. A permanent subcutaneous
electrode was then inserted which activated the auditory
cortex electrode. As a result, noise-like tinnitus reduced to
4/10 and remained so for 5 years, while pure tone tinnitus
remained absent. Despite this, the exact mechanism involved
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in the C2 stimulation for tinnitus relief remains unknown.
Moreover, given that only a single patient was examined, it
is not possible to speculate on its general effectiveness. The
method requires application in a larger group of patients as it
is possible that patients with different tinnitus characteristics
will respond differently to this form of treatment.
Based on the similarity of pain and tinnitus pathways,
ACC and anterior insula have been suggested to be a core
network for the noise cancelling system. Fluctuations of
activity in the ACC and anterior insula determine whether a
near threshold pain stimulus is consciously perceived or not
[71]. A number of anatomical and functional studies indicate
that tinnitus distress may be related to a cortical network
involving the ACC, anterior insula, and the parahippocampal
area [72, 73]. In particular, self-reported tinnitus distress may
be related to increased activity in the dorsal ACC and insula
[40]. De Ridder et al. [74] report the results of a study on
two patients who underwent implantation of electrodes in
the dorsal ACC. Both patients suffered from chronic tinnitus
subjectively rated 10/10 on a scale for loudness and highly on
questionnaire measures of distress. Initially, fMRI was used
to identify target zones for neurostimulation using sound
stimuli matched to the tinnitus frequency. TMS was applied
to various regions including the auditory cortices and the
prefrontal regions over repeated sessions, but this did not
produce lasting benefits to either patient. Subsequently, both
patients underwent surgery for implantation of electrodes in
the dorsal ACC. One patient reported dramatic improvement
in both tinnitus severity and loudness after one week, which
halved from the preoperative stage. Additional stimulation
after four weeks resulted in further reduction of tinnitus
loudness and distress ratings.These effects had remained two
years after implantation. Conversely, the second patient did
not report any change as a result of the implant which was
trialled at various stimulation configurations. The authors
found increased functional connectivity between dorsal
ACC, pregenual ACC, parahippocampal area, and auditory
cortex in the patient who reported improvements in their
tinnitus. The patient who reported no change demonstrated
decreased functional connectivity in this network. Clearly,
while the results of this study offer possibilities for tinnitus
relief, the hypotheses need further evaluation with a
wider pool of tinnitus patients, particularly with regard
to assessment of connectivity. Whether the assessment of
functional connectivity in the specified network is predictive
of postoperative success cannot be ascertained from this.
It is clear that not all patients with tinnitus benefit
from neurostimulation via implanted electrodes. De Ridder
and Vanneste [68] have shown that functional connectivity
analysis based on EEG resting state activity between the audi-
tory cortex and parahippocampus may determine whether a
tinnitus patient will respond to a cortical implant.This might
be a necessary initial step prior to neurosurgery given the
various risks attached with the latter.
3.8. Deep Brain Stimulation. Deep brain stimulation (DBS)
involves the implantation of a neurostimulator within the
brain to deliver electrical pulses. It has been usedwith varying
degrees of success to treat a number of neurological disorders,
most notably movement and affective disorders such as
Parkinson’s disease [75] but also pain [76]. For tinnitus, DBS
aims to disrupt the communication between various parts of
the brain involved by modifying or preventing the abnormal
neural signal from reaching the auditory cortex. A number of
studies have assessed the therapeutic merits of DBS to affect
mainly subcortical (but also cortical) structures which are
thought to be involved in tinnitus including the thalamus and
the inferior cortex.
The first DBS study in tinnitus was a case series reported
by Shi et al. [77]. They collected self-rating and psychoacous-
tic measures of tinnitus loudness in seven patients who were
implanted for movement disorders but also reported having
tinnitus. Electrodes were placed unilaterally or bilaterally in
the ventral intermedius nucleus of the thalamus for control of
involuntary tremors.Three of the seven patients reported qui-
eter tinnitus when DBS was turned on. Decreases in matched
tinnitus loudness were found in two patients exceeding the
range of normal test-retest variations (±2 dB), which agreed
with their subjective rating of their DBS-related tinnitus
changes. Therefore, a placebo effect was ruled out by the
authors. For the two tested patients whose tinnitus responded
to DBS, tinnitus remained suppressed for 15 to 20 minutes
after stimulationwas turned off.None of the patients reported
stimulation-related changes in hearing and audiometry con-
firmed there were no changes in hearing thresholds. The
results indicate that changes in activity within nonauditory
system may be involved in the maintenance of tinnitus. The
ventral medial nucleus is involved in motor functions and
mainly receives input from the cerebellumand the globus pal-
lidus. It is the site of DBS for motor-related movements such
as multiple sclerosis [78] and Parkinson’s disease [79]. How-
ever, it is not clear why stimulation of motor centres affects
the auditory system, and given that hearing thresholds were
not affected, it is unlikely that the stimulation spreads to other
areas of the thalamus that comprise the auditory pathways. In
the two patients who did not respond to stimulation, tinnitus
had existed for more than 20 years, compared to less than
10 years in responders, which the authors suggest possibly
indicating “decreased plasticity in factors related to tinnitus
perception over very long periods of time” ([77] p.286).
In another study, Cheung and Larson [80] applied DBS
to a locus of caudate neurons (area LC), a subsite of striate
nucleus and a part of basal ganglia. The caudate nucleus also
receives input from the auditory cortices. It was assumed
that stimulation of the basal ganglia would disrupt attention
to auditory cortical representations of tinnitus. Six patients
with chronic tinnitus were recruited who were primarily
being treated for Parkinson’s disease or tremors. Five patients
underwent electrical stimulation of the caudate. In one
patient, tinnitus was completely abolished by stimulation.
In the remaining participants, tinnitus was decreased to
varying extents in both ears.Three patients had a preoperative
and postoperative audiogram; none showed any significant
change postoperatively. Overall, the results indicated that LC
neuromodulation byDBS can decrease tinnitus loudness.The
authors speculate that while the LC is not part of the classical
auditory pathway, itmay play a role in integration of phantom
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sensations generated from the central auditory system with
areas involved in perceptual awareness.
The inferior colliculus (IC) and its various subdivisions
are a major relay centre for auditory signals arriving from the
cochlear nucleus. It is situated within the midbrain and plays
a significant role in auditory signal integration and frequency
and pitch processing. Using fMRI, Melcher et al. [81] found
abnormal activity in IC of patients with tinnitus. In order
to assess the potential effects of IC stimulation on tinnitus,
Offutt et al. [82] compared the extent of suppression and
facilitation elicited in the central IC by different stimulation
paradigms. Using a guinea pig model, they found that
stimulation of dorsal IC induces both suppressive and facili-
tatory changes across the central IC which can occur during
stimulation and that these remain after stimulation. Interest-
ingly, stimulation of dorsal IC induced greater suppression
when paired with broadband noise stimulation. The study,
while not using tinnitus induced animals, demonstrates that
stimulation of the dorsal IC can induce plasticity within the
central IC and concomitant changes in activity, whichmay be
applicable in treating tinnitus. Recently, Shekhawat et al. [23]
showed that a combination of noise and cortical stimulation
using TMSmay bemore effective in suppressing tinnitus than
either one alone.The study byOffutt and colleagues can guide
future TMS studies to target the appropriate regions of the
brain for more optimal therapeutic results.
It must be noted that the studies attempting DBS are
principally aimed at alleviating other coexisting conditions
(Parkinson’s disease, tremor). Therefore, the interacting ef-
fects of these comorbidities with tinnitus are not known. Fur-
thermore, a comprehensive explanation of this neuromodu-
lation is not presented. It is not clear how the minute effects
of weak currents exert an effect on isolated neuronmembrane
potentials and lead to significant changes in network dynam-
ics at the cellular (e.g., timing) and/or network levels. It is
also not clear what frequency of oscillations and intensities
are necessary to induce neural changes that improve tinnitus
therapy in patients with differing clinical manifestations.
Such a framework for neuromodulation is currently lacking.
Moreover, it is intriguing that, inmost of the reported studies,
hearing function (audiometric thresholds) is not affected
given that tinnitus is an auditory sensation that primarily
involves the auditory system. Therefore, any changes in the
tinnitus perception would be expected to also affect other
aspects of audition; but none are reported in these studies.
One relevant study was identified as ongoing. van den
Berge and van Dijk are planning a safety/efficacy study
(NCT02630589) involving an auditory brainstem implant for
tinnitus. Ten participants with severe intractable tinnitus will
be neurosurgically implanted, whereby an electrode array is
inserted into the lateral recess of the fourth ventricle and
placed on the cochlear nucleus. This study will add to the
slowly growing body of evidence for the use of invasive
techniques to treat intractable tinnitus.
4. Conclusions
Each tinnitus patient represents a unique combination of
tinnitus characteristics, aetiology, pathophysiology, and
psychoperceptual factors. Therefore, it is unlikely that any
treatment will provide relief for all tinnitus sufferers, as
indeed is demonstrated by the results of the studies reviewed
here. While their precise mechanism may not be known,
noninvasive methods are worth exploring as they seem to
provide comparable benefits to invasive methods, although
this will not be the case for every individual patient. It is
possible that structures involved in neuromodulation are not
involved in generation and maintenance of tinnitus in all
but only a subtype of patients. Therefore, neuromodulation
offers another venue for identifying the subtypes of tinnitus,
which is the goal of a current European-funded Cooperation
in Science and Technology (COST Action) program for a
Tinnitus Research Network (TINNET; http://tinnet.tinni-
tusresearch.net/index.php/2015-10-29-10-22-16/wg-3-neuro-
imaging) to identify subtypes of tinnitus and their neural
correlates and thus develop innovative hypothesis driven
treatment approaches.
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